For a decade India's venture market had a funding problem it had largely solved and an exit problem it had not. In 2021 a series of domestic listings answered the harder question — and answered it in a way that changed what could be built there.
India's venture market had two structural constraints through the 2010s. Funding had been largely resolved — foreign capital was available at scale by the late 2010s. Exits had not, and as the 2019 Asia-Pacific report argues, the exit route determines achievable return independent of operating performance.
2021 addressed the second, and it is the most consequential development in Indian private markets in a decade.
A series of venture-backed companies listed on domestic exchanges. This mattered for reasons beyond the individual transactions:
A domestic route is more durable than an offshore one. As the 2016 and 2021 Asia-Pacific reports describe, offshore listing depends on the rules of two jurisdictions remaining favourable, and those rules are not fixed at the point of investment. A domestic route depends on one, and it is the one the company operates in.
The listings priced unevenly. Some traded well; others fell substantially below their offer price. This is frequently characterised as a failure. It is better read as the market working: public investors applied a different standard than late-stage private investors had, exactly as they did in the US in 2019, and the mechanism is identical.
The distinction deserves setting out because it is the report's central structural claim.
An offshore listing requires:
A domestic listing requires the home jurisdiction's exchange to accept the company. One dependency instead of three.
Why the difference matters more than it appears:
An exit route that depends on two governments is worth less than one that depends on one — and the difference is not a discount, it is a different set of businesses that become fundable.
Several 2021 listings traded below their offer prices. The interpretation matters, and the reflexive one is wrong.
What happened is what the 2019 US venture report describes. Late-stage private valuations had been set by a small number of investors in negotiated rounds. Public listing subjected those valuations to a continuous auction among many participants who could decline to buy.
Where the two standards differed, the price moved. That is the mechanism functioning, not failing.
The specific differences, as in 2019:
Why this is healthy for the market:
The alternative — companies remaining private indefinitely at unvalidated marks — is the condition the 2015 US venture report describes and the 2019 and 2022 reports describe being corrected painfully. India experienced a mild version of that correction in a single year rather than accumulating it for a decade.
Indian venture funding reached record levels in 2021, and part of the explanation lies outside India.
As the 2021 Asia-Pacific report describes, regulatory developments in another large regional market prompted allocators to reduce exposure there. Capital seeking Asian growth exposure reallocated within the region, and India was the principal beneficiary.
Combined with global conditions — the abundant capital environment the 2021 global report describes — this produced very strong inflows.
The consequence is one investors should hold clearly: valuations rose partly for reasons unrelated to Indian fundamentals.
Why that matters:
The honest assessment of 2021 in India: the structural developments were genuine and important — the exit route opening is a lasting change. The valuation environment was substantially imported, and the vintage entered at prices set partly by a regulatory event in a different country.
Those are separable, and they should be separated. The structural improvement is durable. The pricing was not.
The constraint the 2017 report describes had not disappeared, and the 2021 outcomes are informative about it.
The businesses that listed successfully were largely those that had found models working within the income constraint: very large scale with small per-transaction economics; financial services; business-to-business models; or services with a global revenue base and a local cost base.
The businesses that struggled were more often those still pursuing high revenue per user in a market where the addressable segment for that spending is small.
The 2021 abundance temporarily obscured this. Capital availability meant businesses could fund losses for longer, which delays the point at which the constraint binds. It does not remove it — a business whose model requires customers to spend more than they can afford does not become viable because it has more runway.
The subsequent years tested this, as they did globally. Businesses with genuine unit economics continued; those dependent on subsidy faced the reckoning the 2017 report anticipates.
The durable lesson: capital abundance defers the test of a business model. It does not change the answer. That applies well beyond India and is one of the archive's recurring findings — visible in the 2019 US venture report's account of the interrupted correction and in the 2023 report's account of deferrals expiring.
The 2021 listings established that the route existed. Whether it stays open depends on conditions that are worth naming, because a route that opens once and closes is worth considerably less than one that remains available.
A domestic institutional buyer base. A market where new listings are absorbed principally by retail enthusiasm is fragile — retail participation is sentiment-driven and withdraws quickly. Institutional buyers with mandates and longer horizons provide stable demand. The entry of Indian mutual funds and insurers into these companies is the load-bearing development, more than any individual listing.
Acceptable post-listing performance. If a cohort of listings performs poorly, the window closes for subsequent issuers regardless of their quality. This is not a judgement about fairness — it is how the buyer side rations its attention after a bad experience. The uneven 2021 pricing was healthy as price discovery and carries this risk as a consequence.
Listing requirements that venture-stage companies can meet. A market requiring sustained profitability excludes most venture-backed companies by construction. The requirements determine how much of the backlog can clear, and they are a regulatory choice rather than a market condition.
Analyst coverage and liquidity. A listed company with no coverage and thin trading is a poor outcome for the investors who wanted liquidity. The route only works if the shares actually trade.
A comparable set. Once several companies have listed, subsequent ones can be priced against them. Before that, both the issuer and the buyer are pricing without reference points, which widens the range of outcomes and raises the failure rate. The first cohort bears a cost that later cohorts do not, which is part of why 2021's pricing was uneven.
Assessing all five is how to judge whether the route is durable, and each is observable from free exchange and regulatory data.
Separate the structural improvement from the pricing environment. 2021 delivered both: a lasting change in the exit route and an imported valuation environment. The first is durable and the second was not. Conflating them means either dismissing a genuine structural gain because the vintage performed poorly, or defending the vintage's prices by pointing at the structural gain.
Count jurisdictional dependencies in the exit route. An offshore listing depends on two governments remaining permissive throughout the holding period; a domestic route depends on one. The difference is not a discount — it changes which businesses are fundable, because a company that can reach a domestic listing can be built for the domestic market alone.
Read uneven post-listing pricing as the mechanism working. Public markets applying a different standard than late-stage private investors is price discovery, not failure. It establishes comparables, disciplines private pricing, and surfaces information — and the alternative, companies remaining private at unvalidated marks, is the condition the 2015 US venture report describes accumulating for a decade.
Compute the implied common value from the prospectus. Draft red herring prospectuses filed with SEBI are free and contain the pre-listing capitalisation table. The gap between the headline private valuation and the implied common-share value is computable rather than estimated, and preference structure inflation disappears mechanically at listing.
Watch for capital arriving on conditions elsewhere. A sharp rise in foreign participation share alongside rising valuations, with deal count flat or falling, indicates price being set by inflows rather than by assessment. That combination preceded the 2021 vintage's difficulties and the diagnostic is available in the data.
Note that abundance defers a business model test rather than answering it. Businesses whose models required customers to spend more than the addressable segment could afford did not become viable because they had more runway. The 2023 India report describes the answer arriving.
A structural retrospective on Indian venture capital in 2021, focused on the opening of the domestic exit route and what it changed.
Where figures appear they carry a numbered source. Mechanisms — single versus dual jurisdictional dependency, public auction versus negotiated pricing, price insensitivity in reallocated capital, deferral versus resolution of business model tests — are analysis with reasoning shown.
This report follows the 2017 India report and is the country companion to the 2021 Asia-Pacific report.
India Venture Capital Report 2017 sets out the constraints this report describes being partially resolved — the income arithmetic that bounds business model viability, the subsidised-metrics problem, and the exit route as the binding constraint on achievable return.
India Venture Capital Report 2023 describes the contraction that followed, why it measured foreign capital withdrawal rather than deteriorating local conditions, and why measuring from an inflated peak overstates a decline.
India Venture Capital Outlook 2026 closes the sequence, separating the allocation question from the entry price question.
US Venture Capital Report 2019 develops the disclosure-test framework this report applies to the 2021 listings — why a public listing is a different test rather than a stricter one, and why preference structure inflates headline private valuations by an amount computable from the capitalisation table.
Asia-Pacific Investment Report 2021 describes the regulatory repricing in another regional market that redirected capital toward India, and why capital arriving for reasons originating elsewhere is less price-sensitive than capital arriving on an assessment of the destination.
Global Investment Outlook 2021 and US Venture Capital Report 2021 cover the abundant capital environment that compounded the reallocation, and establish entry price as the dominant determinant of a vintage's return.
Asia-Pacific Investment Report 2019 develops the exit route framework — time to exit, achievable valuation and probability of exit — that explains why the domestic listing route opening mattered as much as it did.
Accredited investors receive our market reports, private event invitations and curated deal flow.
.png)




